These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

190 related articles for article (PubMed ID: 27123091)

  • 1. Efficacy of peritoneovenous shunt for treating tolvaptan-resistant refractory ascites in a cirrhotic patient with portal vein thrombosis: A case report.
    Shigeto K; Kawaguchi T; Niizeki T; Kunitake Y; Takedatsu H; Tonan T; Fujimoto K; Tanaka M; Abe T; Naito H; Torimura T
    Oncol Lett; 2016 May; 11(5):3205-3209. PubMed ID: 27123091
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Prognosis assessment of cirrhotic patients with refractory ascites treated with a peritoneovenous shunt.
    Guardiola J; Xiol X; Escribá JM; Castellví JM; Castellote J; Baliellas C; Rafecas A; Casais LA
    Am J Gastroenterol; 1995 Dec; 90(12):2097-102. PubMed ID: 8540495
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Paracentesis with intravenous infusion of albumin as compared with peritoneovenous shunting in cirrhosis with refractory ascites.
    Ginès P; Arroyo V; Vargas V; Planas R; Casafont F; Panés J; Hoyos M; Viladomiu L; Rimola A; Morillas R
    N Engl J Med; 1991 Sep; 325(12):829-35. PubMed ID: 1875966
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Primary Intestinal Lymphangiectasia Successfully Controlled with a Denver Peritoneovenous Shunt for Refractory Ascites.
    Sekine K; Shimada F; Suzuki T
    Intern Med; 2024 Jun; 63(12):1703-1706. PubMed ID: 37952951
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Predictive parameter of tolvaptan effectiveness in cirrhotic ascites.
    Kawaratani H; Fukui H; Moriya K; Noguchi R; Namisaki T; Uejima M; Kitade M; Takeda K; Okura Y; Kaji K; Nishimura N; Takaya H; Aihara Y; Sawada Y; Sato S; Seki K; Mitoro A; Yamao J; Yoshiji H
    Hepatol Res; 2017 Aug; 47(9):854-861. PubMed ID: 27704665
    [TBL] [Abstract][Full Text] [Related]  

  • 6. [Peritoneovenous diversion using the LeVeen shunt in the treatment of refractory ascites after liver transplantation].
    Mabrut JY; de la Roche E; Adham M; Ducerf C; Baulieux J
    Ann Chir; 1998; 52(7):612-7. PubMed ID: 9805798
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Chronological Course and Clinical Features after Denver Peritoneovenous Shunt Placement in Decompensated Liver Cirrhosis.
    Koyama S; Nogami A; Yoneda M; Cheng S; Koike Y; Takeuchi Y; Iwaki M; Kobayashi T; Saito S; Utsunomiya D; Nakajima A
    Tomography; 2024 Mar; 10(4):471-479. PubMed ID: 38668394
    [TBL] [Abstract][Full Text] [Related]  

  • 8. [Clinical Study of Peritoneovenous Shunt for Patients with Refractory Ascites Accompanied with Hepatocellular Carcinoma].
    Nakajima T; Aihara T; Ikuta S; Tomoo Y; Nomura K; Matsuki G; Fujikawa M; Ichise N; Kasai M; Okamoto R; Nakamoto Y; Yanagi H; Yamanaka N
    Gan To Kagaku Ryoho; 2022 Dec; 49(13):1576-1578. PubMed ID: 36733140
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Ascites symptom inventory-7 is a valuable tool for evaluating the effectiveness of tolvaptan in patients with cirrhotic ascites.
    Kawaratani H; Moriya K; Namisaki T; Shimozato N; Kaji K; Takaya H; Fujinaga Y; Sawada Y; Sato S; Saikawa S; Kubo T; Akahane T; Fukui H; Yoshiji H
    Exp Ther Med; 2021 Jan; 21(1):30. PubMed ID: 33262816
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Peritoneovenous shunt for intractable ascites of hepatic, nephrogenic, and malignant causes.
    Holm A; Halpern NB; Aldrete JS
    Am J Surg; 1989 Aug; 158(2):162-6. PubMed ID: 2757146
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Peritoneovenous shunt scintigraphy to assess shunt patency in patients with refractory ascites.
    Senthil R; Sundaraiya S; Perumalla R; Rela M
    J Clin Exp Hepatol; 2013 Dec; 3(4):347-50. PubMed ID: 25755522
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Refractory ascites due to portal vein thrombosis in liver cirrhosis--report of two cases.
    Tanaka H; Horie Y; Idobe Y; Murawaki Y; Suou T; Kawasaki H
    Hepatogastroenterology; 1998; 45(23):1777-80. PubMed ID: 9840147
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Treatment for cirrhotic ascites.
    Kawaratani H; Fukui H; Yoshiji H
    Hepatol Res; 2017 Feb; 47(2):166-177. PubMed ID: 27363974
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Peritoneovenous shunt for intractable ascites due to hepatic lymphorrhea after hepatectomy.
    Inoue Y; Hayashi M; Hirokawa F; Takeshita A; Tanigawa N
    World J Gastrointest Surg; 2011 Jan; 3(1):16-20. PubMed ID: 21286221
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Tolvaptan is effective in treating patients with refractory ascites due to cirrhosis.
    Tahara T; Mori K; Mochizuki M; Ishiyama R; Noda M; Hoshi H; Lefor AK; Shinozaki S
    Biomed Rep; 2017 Dec; 7(6):558-562. PubMed ID: 29250327
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Percutaneous implant of Denver peritoneo-venous shunt for treatment of refractory ascites: a single center retrospective study.
    Piccirillo M; Rinaldi L; Leongito M; Amore A; Crispo A; Granata V; Aprea P; Izzo F
    Eur Rev Med Pharmacol Sci; 2017 Aug; 21(16):3668-3673. PubMed ID: 28925475
    [TBL] [Abstract][Full Text] [Related]  

  • 17. [Role of surgery in the treatment of refractory ascites in cirrhotic patients].
    Borie DC; Vaillant JC; Breton S; Hannoun L
    Ann Chir; 1999; 53(10):966-72. PubMed ID: 10670142
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Peritoneovenous shunt function 2-6 years after insertion for cirrhotic ascites.
    Stanley MM; VanDrunen M; Greenlee HB
    ASAIO Trans; 1989; 35(2):170-4. PubMed ID: 2730817
    [TBL] [Abstract][Full Text] [Related]  

  • 19. TIPS versus peritoneovenous shunt in the treatment of medically intractable ascites: a prospective randomized trial.
    Rosemurgy AS; Zervos EE; Clark WC; Thometz DP; Black TJ; Zwiebel BR; Kudryk BT; Grundy LS; Carey LC
    Ann Surg; 2004 Jun; 239(6):883-9; discussion 889-91. PubMed ID: 15166968
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Morbidity and mortality after peritoneovenous shunt surgery for refractory ascites.
    Rubinstein D; McInnes I; Dudley F
    Gut; 1985 Oct; 26(10):1070-3. PubMed ID: 4054706
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 10.